Format

Send to

Choose Destination
Radiother Oncol. 2015 Dec;117(3):559-81. doi: 10.1016/j.radonc.2015.11.013. Epub 2015 Dec 9.

ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.

Author information

1
Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy. Electronic address: clinicalguidelines@esmo.org.
2
Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
3
Department of Gynecological Oncology, University Hospital Leuven, Leuven, Belgium; Center for Gynecological Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
4
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
5
Medical Oncology Department, GEICO, Madrid, Spain; MD Anderson Cancer Center, Madrid, Spain.
6
Department of Oncology and Cancer Trials, UCL Cancer Institute, London, United Kingdom.
7
Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.
8
Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
9
Department of Surgery, Institut Bergonié, Bordeaux, France; Gynecology and Obstetrics Department, McGill University Health Centre, Montreal, Canada.
10
Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
11
Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

Abstract

The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: Prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.

KEYWORDS:

Adjuvant; Consensus; Endometrial neoplasms; Practice guideline; Surgery; Treatment

PMID:
26683800
DOI:
10.1016/j.radonc.2015.11.013
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center